AAVnerGene

AAVnerGene is an innovation-driven biotechnology company dedicated to developing next-generation AAV vector technologies. The company owns self-developed platforms, including AAVone (a high-yield single-plasmid AAV production system that significantly reduces production costs) and ATHENA (an advanced capsid engineering platform enabling precise tissue targeting). AAVnerGene is committed to providing affordable, scalable, and precisely designed gene therapy solutions to accelerate clinical development across various therapeutic fields.